Brief: Venus Remedies Secures New Marketing Authorizations For Docetaxel And Gemcitabine In Malta, Europe
12/01/2024 06:34
Jan 12 (Reuters) - Venus Remedies Ltd VENR.NS :
* SECURES NEW MARKETING AUTHORIZATIONS FOR DOCETAXEL AND
GEMCITABINE IN MALTA, EUROPE
Source text for Eikon: ID:nBSE9X8x9w
Further company coverage: VENR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage